With the advent of the SARS-CoV-2 pandemic, diagnostics (testing), and therapeutics (anti-virals, vaccines) are dominating the news. The critical role of diagnostics and therapeutics places a special responsibility on our community of researchers, and this has created a unique environment, motivating us to announce a fundamental restructuring of Institute for Precision Health activities and investments to address the challenge and opportunity of SARS-CoV-2. This restructuring has received the enthusiastic approval of the IPH Steering Committee as well as the Vice President for Research.

Deadline

The application period is currently closed. Please check back in Spring 2021 for the next application period.

Application

PIs must provide a two page (maximum) research proposal that includes the following elements:

  • Title
  • PI(s)
  • Project summary of the externally funded project, including sponsor, dates, and total direct costs
  • A statement of proposed new work, including relevance to programmatic areas, specific experimental or computational research objectives, and potential impact of the proposed extension on public health broadly understood

In addition (not counting toward the 2-page maximum), we require a budget and brief justification.

All proposals should be submitted by e-mail to precisionhealth@nd.edu as a single PDF file.

Evaluation Criteria

All applications will be reviewed and rated according to:

  • Scientific excellence
  • Relevance to the program objectives
  • Feasibility of the research plan
  • Potential for technology translation
  • Capacity to leverage existing resources

Review Process

After the peer-review ratings are received, the proposals will be ranked and a proposed set of funded projects presented to the IPH Steering Committee for approval. Proposals may be single- or multi-PI (but the lead PI must be a Notre Dame faculty member) and should address as many of the evaluation criteria as possible. IPH has allocated $250,000 for this program and provided six awards for research in AY20-21.

All awards and research activities supported by this program are subject to the guidance on research continuity, including laboratory access and expenditures of internal funds, issued by Notre Dame Research. If research grants are approved prior to laboratory access being available, the grant period will be coordinated with the commencement of laboratory operations.

In case there is any ambiguity about external funding data, the NDR Cayuse system will be considered the official record.

This award opportunity replaces the IPH Discovery Fund Seed Grant program, which ordinarily would accept applications in this time window. A separate call for substance abuse research seed grants, which are donor-supported and limited to this topic, will be released in the future.

Need More Information?

Please contact precisionhealth@nd.edu with any questions.